Literature DB >> 16041680

Monoamniotic twins discordant for anencephaly managed conservatively with good outcomes: two case reports and a review of the literature.

K I Lim1, C Dy, D Pugash, K P Williams.   

Abstract

Monoamniotic twin pregnancy discordant for anencephaly (MATDA) is a rare occurrence with only seven prior reported cases. Selective termination has been advocated in managing discordant monoamniotic twins. We report two cases managed expectantly with good outcomes and review other previously reported cases. The first case was a primigravid woman diagnosed with MATDA at 18 weeks. She was managed expectantly until 32 + 5 weeks when a Cesarean section was performed for preterm labor. The surviving female infant weighed 1610 g. The second case was a multigravid woman who was diagnosed with MATDA at 17 + 5 weeks and was managed as an outpatient. An emergency Cesarean section was performed at 31 weeks for non-reassuring monitoring and the surviving male infant weighed 1790 g. In both cases, the survivors were discharged home in good condition. A review of these two cases and those in the literature suggests that expectant management should be considered among management options for this rare condition. Copyright 2005 ISUOG. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2005        PMID: 16041680     DOI: 10.1002/uog.1947

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  2 in total

1.  Monoamniotic twins with one fetal anencephaly and cord entanglement diagnosed with three dimensional ultrasound at 14 weeks of gestation.

Authors:  Yun Sung Jo; Hyun Joo Son; Dong Gyu Jang; Narinay Kim; Guisera Lee
Journal:  Int J Med Sci       Date:  2011-09-29       Impact factor: 3.738

2.  Deficient Vitamin E Uptake During Development Impairs Neural Tube Closure in Mice Lacking Lipoprotein Receptor SR-BI.

Authors:  Nicolás Santander; Carlos Lizama; María José Parga; Alonso Quiroz; Druso Pérez; Guadalupe Echeverría; Lorena Ulloa; Verónica Palma; Attilio Rigotti; Dolores Busso
Journal:  Sci Rep       Date:  2017-07-12       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.